Physician profile
James Shoptaw Jr
NPI 1710951942
$2,617.88
in general payments reported to CMS, 2019-2025
36 companies · $361 in 2025
The $361 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $403 · 2020: $558 · 2021: $373 · 2022: $289 · 2023: $381 · 2024: $254 · 2025: $361.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $995.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $995.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $502.86 | 2020-2021 | |
| Atricure, INC. | $299.73 | 2019-2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| Covidien LP | $218.08 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $158.86 | 2019-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $114.88 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $110.16 | 2019-2021 | |
| Medtronic, INC. | $98.70 | 2021-2025 | Endurant Iis |
| La Jolla Pharmaceutical Company | $96.74 | 2021-2024 | Giapreza |
| Abbott Laboratories | $89.27 | 2022-2025 | Esprit, Supera, Emboshield Nav6 |
| Boston Scientific Corporation | $81.04 | 2024-2025 | Bodyguardian, Watchman Flx, Enroute Transcarotid Neuroprotection System |
| Pfizer INC. | $78.66 | 2022-2025 | |
| Bolton Medical INC | $73.75 | 2024-2025 | Treo Abdominal Stent-Graft System |
| Medtronic Vascular, INC. | $64.11 | 2019-2020 | |
| Baxter Healthcare | $61.46 | 2021-2023 | Floseal |
| Hemosonics LLC | $44.85 | 2023 | Quantra Qplus System |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $42.80 | 2023 | Imfinzi, Andexxa |
| Abiomed | $39.88 | 2023-2024 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.78 | 2022 | |
| Shionogi INC | $37.39 | 2023-2024 | Fetroja |
| Terumo Medical Corporation | $35.47 | 2020-2022 | |
| Chiesi USA, INC. | $34.56 | 2019 | |
| W. L. Gore & Associates, INC. | $33.88 | 2023-2024 | Gore Tag Conformable Thoracic Endoprosthesis |
| Bard Peripheral Vascular, INC. | $26.19 | 2022 | |
| Merck Sharp & Dohme LLC | $24.18 | 2023 | Keytruda |
| Genzyme Corporation | $23.83 | 2022 | |
| Kci USA, INC. | $22.74 | 2021 | |
| Lundbeck LLC | $21.70 | 2021 | |
| Lsi Solutions INC | $21.48 | 2023 | Cor Knot |
| Angiodynamics, INC. | $20.81 | 2021 | |
| Molnlycke Health Care US, LLC | $19.69 | 2020 | |
| Thrombolex, INC. | $18.43 | 2024 | Bashir Endovascular Catheter |
| Silk Road Medical, INC. | $14.69 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Getinge USA Sales, LLC | $13.79 | 2020 | |
| Philips North America LLC | $13.74 | 2023 | |
| Olympus America INC. | $12.94 | 2022 | |
| Lexington Medical, INC. | $8.76 | 2023 | Aeon Endostapler & Echelon Flex Powered Stapler |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Shoptaw Jr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.